GNS Fundamental Analysis - GENIUS GROUP LTD

Fundamental Rating

Taking everything into account, GNS scores 2 out of 10 in our fundamental rating. GNS was compared to 77 industry peers in the Diversified Consumer Services industry. GNS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GNS is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year GNS has reported negative net income.

In the past year GNS has reported a negative cash flow from operations.

In the past 5 years GNS always reported negative net income.

GNS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

GNS has a worse Return On Assets (-29.26%) than 72.73% of its industry peers.

GNS's Return On Equity of -39.98% is on the low side compared to the rest of the industry. GNS is outperformed by 62.34% of its industry peers.

		Industry Rank	Sector Rank
ROA	-29.26%
ROE	-39.98%
ROIC	N/A

ROA(3y)-32.95%

ROA(5y)-28.35%

ROE(3y)-284.46%

ROE(5y)-202.75%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

GNS has a Gross Margin of 32.64%. This is in the lower half of the industry: GNS underperforms 62.34% of its industry peers.

GNS's Gross Margin has declined in the last couple of years.

GNS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	32.64%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.61%

GM growth 5Y-7.99%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

GNS does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for GNS has been increased compared to 1 year ago.

GNS has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, GNS has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.74, we must say that GNS is in the distress zone and has some risk of bankruptcy.

GNS has a worse Altman-Z score (-0.74) than 66.23% of its industry peers.

GNS has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.

GNS's Debt to Equity ratio of 0.08 is fine compared to the rest of the industry. GNS outperforms 62.34% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.08
Debt/FCF	N/A
Altman-Z	-0.74

ROIC/WACCN/A

WACC8.72%

2.3 Liquidity

GNS has a Current Ratio of 2.16. This indicates that GNS is financially healthy and has no problem in meeting its short term obligations.

GNS's Current ratio of 2.16 is fine compared to the rest of the industry. GNS outperforms 77.92% of its industry peers.

GNS has a Quick Ratio of 2.12. This indicates that GNS is financially healthy and has no problem in meeting its short term obligations.

GNS has a Quick ratio of 2.12. This is in the better half of the industry: GNS outperforms 77.92% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.16
Quick Ratio	2.12

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

GNS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.33%.

Looking at the last year, GNS shows a very negative growth in Revenue. The Revenue has decreased by -65.69% in the last year.

The Revenue has been decreasing by -4.48% on average over the past years.

EPS 1Y (TTM)-13.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%52.34%

Revenue 1Y (TTM)-65.69%

Revenue growth 3Y-1.56%

Revenue growth 5Y-4.48%

Sales Q2Q%-44.32%

3.2 Future

GNS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.21% yearly.

The Revenue is expected to grow by 22.53% on average over the next years. This is a very strong growth

EPS Next Y62.92%

EPS Next 2Y38.21%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-19.23%

Revenue Next 2Y22.53%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

GNS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year GNS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

GNS's earnings are expected to grow with 38.21% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y38.21%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for GNS!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

GENIUS GROUP LTD

NYSEARCA:GNS (12/22/2025, 8:04:00 PM)

After market: 0.6664 0 (-0.24%)

0.668

-0.03 (-4.84%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Services

GICS IndustryDiversified Consumer Services

Earnings (Last)09-23 2025-09-23

Earnings (Next)N/A N/A

Inst Owners2.33%

Inst Owner Change-28.38%

Ins Owners8.57%

Ins Owner ChangeN/A

Market Cap58.66M

Revenue(TTM)7.91M

Net Income(TTM)-24.88M

AnalystsN/A

Price Target3.47 (419.46%)

Short Float %8.33%

Short Ratio1.95

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-20.93%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-135.71%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)12.67%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	7.41
P/FCF	N/A
P/OCF	N/A
P/B	0.94
P/tB	1.37
EV/EBITDA	N/A

EPS(TTM)-1.03

EYN/A

EPS(NY)-0.08

Fwd EYN/A

FCF(TTM)-0.59

FCFYN/A

OCF(TTM)-0.51

OCFYN/A

SpS0.09

BVpS0.71

TBVpS0.49

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-29.26%
ROE	-39.98%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	32.64%
FCFM	N/A

ROA(3y)-32.95%

ROA(5y)-28.35%

ROE(3y)-284.46%

ROE(5y)-202.75%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.61%

GM growth 5Y-7.99%

F-Score0

Asset Turnover0.09

Health

		Industry Rank	Sector Rank
Debt/Equity	0.08
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	338.28%
Cap/Sales	88.07%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.16
Quick Ratio	2.12
Altman-Z	-0.74

F-Score0

WACC8.72%

ROIC/WACCN/A

Cap/Depr(3y)138.36%

Cap/Depr(5y)102.77%

Cap/Sales(3y)32.99%

Cap/Sales(5y)23.68%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-13.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%52.34%

EPS Next Y62.92%

EPS Next 2Y38.21%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-65.69%

Revenue growth 3Y-1.56%

Revenue growth 5Y-4.48%

Sales Q2Q%-44.32%

Revenue Next Year-19.23%

Revenue Next 2Y22.53%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-3.37%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year21.95%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-311.78%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-273.5%

OCF growth 3YN/A

OCF growth 5YN/A

GENIUS GROUP LTD / GNS FAQ

What is the fundamental rating for GNS stock?

ChartMill assigns a fundamental rating of 2 / 10 to GNS.

Can you provide the valuation status for GENIUS GROUP LTD?

ChartMill assigns a valuation rating of 1 / 10 to GENIUS GROUP LTD (GNS). This can be considered as Overvalued.

How profitable is GENIUS GROUP LTD (GNS) stock?

GENIUS GROUP LTD (GNS) has a profitability rating of 0 / 10.

What is the earnings growth outlook for GENIUS GROUP LTD?

The Earnings per Share (EPS) of GENIUS GROUP LTD (GNS) is expected to grow by 62.92% in the next year.

GENIUS GROUP LTD (GNS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

GENIUS GROUP LTD / GNS FAQ

What is the fundamental rating for GNS stock?

Can you provide the valuation status for GENIUS GROUP LTD?

How profitable is GENIUS GROUP LTD (GNS) stock?

What is the earnings growth outlook for GENIUS GROUP LTD?